Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: With particular emphasis on donor major histocompatibility complex class II+ cells

Transplantation

Volumn 74, Issue 1, 2002, Pages 103-111

  Okuda, Toyokazu ^a   Ishikawa, Takashi ^a   Azhipa, Olga ^a   Ichikawa, Naoya ^a   Demetris, Anthony J ^a   Starzl, Thomas E ^a   Murase, Noriko ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TACROLIMUS;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; GRAFT REJECTION; HISTOPATHOLOGY; IMMUNITY; IMMUNOCYTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE MIGRATION; LIVER TRANSPLANTATION; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN TRANSPLANTATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 0037099164     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200207150-00018     Document Type: Article

References (53)

1. Antigen localization and migration in immunity and tolerance
2. Regulation of transplant rejection, engraftment, and tolerance by antigen migration and localization: An historical perspective. Nature Reviews
3. Cell migration, chimerism, and graft acceptance
4. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
5. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats
6. Induction of immunological tolerance by porcine liver allografts
7. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens
8. Primary vascularized allografts of hearts in mice. The role of H-2D, H-2K and non-H-2 antigens in rejection
9. Kidney transplants in mice: An analysis of the immune status of mice bearing long-term H-2 incompatible transplants
10. Rejection of the multivisceral allografts in rats: A sequential analysis with comparison to isolated orthotopic small bowel and liver grafts
11. Murine liver allograft transplantation: Tolerance and donor cell chimerism
12. Chimerism and transpantation tolerance: Cause and effect
13. Mixed chimerism as an approach for the induction of transplantation tolerance
14. Donor-type microchimerism associated with graft rejection eight years after liver transplantation
15. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat
16. Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression
17. Hematolymphoid cell trafficking, microchimerism, and GVHD reactions after liver, bone marrow, and heart transplantation
18. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor
19. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor-strain dendritic cells
20. Dendritic cells in transplantation - Friend or foe?
21. The dendritic cell system and its role in immunogenicity
22. Microchimerism, dendritic cell progenitors and transplantation tolerance
23. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption
24. Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization
25. A monoclonal antibody (L21-6) recognizing an invariant chain expressed on the cell surface in rats with the exception of the BN (RT1n): A study of tissue and strain distributions
26. The major histocompatibility complex of the rat
27. The surface phenotype of dendritic cells purified from mouse thymus and spleen: Investigation of the CD8 expression by a subpopulation of dendritic cells
28. Pathology of the orthotopic homograft and heterograft
29. Long survival in rats after multivisceral versus isolated small bowel allotransplantation under FK 506
30. Replacement of donor lymphoid tissue in human small bowel transplants under FK 506 immunosuppression
31. Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity
32. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel route for initiation of rejection
33. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction
34. High-dose/activation-associated tolerance
35. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: With particular reference to chronic rejection
36. Lymphoid/non-lymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow
37. Donor hematopoietic progenitor cells in non myeloablated rat recipients of allogeneic bone marrow and liver grafts
38. The role of IL-10 in crossregulation of TH1 and TH2 responses
39. Cytokines and the Th1/Th2 paradigm in transplantation
40. Molecular exploration of the anti-allograft response
41. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution
42. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choiromeningitis within a syngeneic or semiallogeneic system
43. Indirect presentation of MHC antigens in transplantation
44. Chronic allograft dysfunction: Mechanisms and new approaches to therapy
45. Direct and indirect recognition: The role of MHC antigens in graft rejection
46. Allorecognition
47. Roles of tumor-localization, second signals, and cross-priming in cytotoxic T-cell induction
48. CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts
49. The role of the class II transactivator (CIITA) in MHC class I and II regulation and graft rejection in kidney
50. Rapid rejection of HLA-A2 Transgenic skin graft due to indirect allorecognition
51. Tolerance, danger, and the extended family
52. The wisdom of hindsight